China Pharma Holdings, Revenue Growth Rates (CHPI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
China Pharma Holdings, Inc.  (CHPI)
 

CHPI's Revenue Growth by Quarter and Year

China Pharma Holdings,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CHPI Revenue (in millions $) FY 2015 FY 2014 FY 2013 FY 2012
4th Quarter December -
3rd Quarter September -
2nd Quarter June 2.17
1st Quarter March 2.11
FY 4.28





CHPI Revenue second quarter 2015 Y/Y Growth Comment
China Pharma Holdings, Inc. reported fall in Revenue in the second quarter 2015 by -34.16% to $ 2.17 millions, from the same quarter in 2014.
The drop in the second quarter 2015 China Pharma Holdings, Inc.'s Revenue compares unfavorably to the Company's average Revenue growth of 7.59%.

Looking into second quarter 2015 results within Major Pharmaceutical Preparations industry 149 other companies have achieved higher Revenue growth. While China Pharma Holdings, Inc.' s Revenue drop of -34.16% ranks overall at the positon no. 3649 in the second quarter 2015.


CHPI Revenue ( Y/Y Growth %) 2015
 2014 2013 2012
4th Quarter December - -18.8 % - -
3rd Quarter September - 35.75 % - -
2nd Quarter June -34.16 % - - -
1st Quarter March -4.52 % - - -
FY   - 124.18 % - -

Financial Statements
China Pharma Holdings,'s second quarter 2015 Revenue $ 2.17 millions CHPI's Income Statement
China Pharma Holdings,'s second quarter 2014 Revenue $ 3.30 millions Quarterly CHPI's Income Statement


CHPI Revenue (Quarter on Quarter Growth %)

 2015
 2014 2013 2012
4th Quarter December - -17.56 % 37.82 % -
3rd Quarter September - -20.61 % - -
2nd Quarter June 2.97 % 49.32 % - -
1st Quarter March -2.31 % -16.92 % - -
FY (Year on Year)   - 124.18 % - -


Back to CHPI Growth rate Comparisons >> Back to CHPI Growth rate Comparisons >>


Revenue second quarter 2015 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #150
Healthcare Sector #413
Overall #3649

Revenue Y/Y Growth Statistics
High Average Low
70.6 % 7.59 % -34.18 %
(Jun 30 2011)   (Sep 30 2011)
Revenue second quarter 2015 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #150
Healthcare Sector #413
Overall #3649
Revenue Y/Y Growth Statistics
High Average Low
70.6 % 7.59 % -34.18 %
(Jun 30 2011)   (Sep 30 2011)

Revenue by Quarter for the Fiscal Years 2012, 2013, 2014, 2015

China Pharma Holdings,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
49.15 % 8.22 % -20.48 %
(Jun 30 2011)  


CHPI's II. Quarter Q/Q Revenue Comment
China Pharma Holdings, Inc. achieved in the II. Quarter 2015 below company average Revenue growth of 2.97% quarter on quarter, to $ 2.17 millions.

Within Major Pharmaceutical Preparations industry 118 other companies have achieved higher Revenue quarter on quarter growth. While China Pharma Holdings,'s Revenue growth quarter on quarter, overall rank is 1825.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #119
Healthcare Sector #288
Overall #1825
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #119
Healthcare Sector #288
Overall #1825
Revenue Q/Q Growth Statistics
High Average Low
49.15 % 8.22 % -20.48 %
(Jun 30 2011)  


CHPI's II. Quarter Q/Q Revenue Comment
China Pharma Holdings, Inc. achieved in the II. Quarter 2015 below company average Revenue growth of 2.97% quarter on quarter, to $ 2.17 millions.

Within Major Pharmaceutical Preparations industry 118 other companies have achieved higher Revenue quarter on quarter growth. While China Pharma Holdings,'s Revenue growth quarter on quarter, overall rank is 1825.


China Pharma Holdings,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2012)		 12 Months Ending
(Mar 31 2012)		 12 Months Ending
(Sep 30 2011)		 12 Months Ending
(Jun 30 2011)		 12 Months Ending
Cumulative Revenue 12 Months Ending $ 9.07 $ 0.00 $ 0.00 $ 3.30 $ 0.00
Y / Y Revenue Growth (TTM) -10.34 % - - - -
Year on Year Revenue Growth Overall Ranking # 3137 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) -11.07 % - - - -
Seq. Revenue Growth (TTM) Overall Ranking # 3151 # 3642 # 3643 # 3643 # 0


Cumulative Revenue growth Comment
China Pharma Holdings, showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2012. If the fiscal year would end in Jun 30 2012, China Pharma Holdings,'s annual Revenue fall would be -10.34% year on year to $9 millions.

In the Healthcare sector 326 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3137.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 111
Healthcare Sector # 327
Overall # 3137

Revenue TTM Y/Y Growth Statistics
High Average Low
-10.34 %
 -10.34 %
-10.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 111
Sector # 327
S&P 500 # 3151
Cumulative Revenue growth Comment
China Pharma Holdings, showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2012. If the fiscal year would end in Jun 30 2012, China Pharma Holdings,'s annual Revenue decrease would be -10.34% year on year to $9 millions.

In the Healthcare sector 326 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3137.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 111
Healthcare Sector # 327
Overall # 3137

Revenue TTM Y/Y Growth Statistics
High Average Low
-10.34 %
-10.34 %
-10.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 111
Sector # 327
S&P 500 # 3151




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CHPI's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Jun 30 2012 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2012
Oncternal Therapeutics Inc -0.36%$ -0.365 millions
Biomimetic Therapeutics, Inc.-0.50%$ -0.503 millions
Exact Sciences Corporation-0.58%$ -0.576 millions
Icu Medical Inc-0.66%$ -0.662 millions
Johnson and Johnson-0.74%$ -0.735 millions
American Bio Medica Corporation-0.97%$ -0.965 millions
Filana Therapeutics Inc -1.02%$ -1.017 millions
Zimmer Biomet Holdings Inc -1.09%$ -1.090 millions
Charles River Laboratories International inc -1.23%$ -1.228 millions
Yunhong Green Cti Ltd -1.24%$ -1.240 millions
Atrion Corporation-1.45%$ -1.445 millions
Becton Dickinson And Company-1.67%$ -1.666 millions
3m Company-1.90%$ -1.901 millions
Bio rad Laboratories Inc -2.15%$ -2.154 millions
St Jude Medical Inc-2.54%$ -2.540 millions
Encision Inc -2.60%$ -2.601 millions
Diversicare Healthcare Services Inc -2.63%$ -2.627 millions
Sarepta Therapeutics Inc -3.26%$ -3.263 millions
Utah Medical Products Inc-3.39%$ -3.392 millions
Tenet Healthcare Corp-4.59%$ -4.591 millions
Premier Air Charter Holdings Inc -4.62%$ -4.622 millions
Dynatronics Corporation-4.72%$ -4.722 millions
Lemaitre Vascular Inc -4.97%$ -4.970 millions
Alphatec Holdings Inc -5.16%$ -5.165 millions
International Stem Cell Corporation-5.23%$ -5.232 millions
Milestone Scientific Inc -5.57%$ -5.566 millions
Immucell Corporation-5.80%$ -5.797 millions
Reliv International Inc-6.76%$ -6.763 millions
Wright Medical Group N v -6.96%$ -6.962 millions
China Pediatric Pharmaceuticals, Inc.-7.19%$ -7.192 millions


About China Pharma Holdings, Revenue Growth Rates (CHPI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.